Lectures and seminars Neuroscience seminar for doctoral students with Rik Van der Kant: "The role of lipids in Alzheimer's disease"

Rik van der Kant is an assistant professor with a dual position at the Vrije Universiteit Amsterdam Center for Neurogenomics and Cognitive Research (CNCR) and the Alzheimer Center of the Amsterdam University Medical Center. His lab studies the molecular mechanisms underlying Alzheimer’s disease (AD), and other dementias in the elderly. Work in the van der Kant labs focusses on the role of lipid metabolism in these diseases, and the use of human iPSC-derived neuronal models to discover how lipid metabolism contributes to early pathogenesis. Dr. van der Kant is currently co-leading a clinical phase 2a trial (CHOlesterol Conversion for Late onset AD, CHOCOLAD) to evaluate the efficacy of low-dose Efavirenz as a brain-cholesterol lowering drug for the treatment of early Alzheimer’s disease an co-founder of the CANDIDATE center for CNS drug discovery in Amsterdam.

Career Session

Please note there will be a Career Session later on in the afternoon, at 16:00 in room C0335 in Biomedicum. You can register for both events below.